AJP - Endocrinology and Metabolism, Vol 269, Issue 5 E918-E926, Copyright © 1995 by American Physiological Society

ARTICLES

Osteogenic protein-1 enhances phenotypic expression in ROS 17/2.8 cells

A. M. Kitten, J. C. Lee and M. S. Olson
Department of Biochemistry, University of Texas Health Science Center, San Antonio 78284-7760, USA.

Osteogenic protein-1 (OP-1) stimulates bone morphogenesis in vivo and modulates osteoblast growth and differentiation in vitro. Treatment of ROS 17/2.8 cells with OP-1 resulted in a time- and concentration-dependent inhibition of [3H]thymidine incorporation. In contrast, OP-1 treatment stimulated phenotypic differentiation in ROS 17/2.8 cells, as indicated by enhanced 1) alkaline phosphatase activity (4-fold); 2) alkaline phosphatase mRNA (5-fold); 3) parathyroid hormone receptor mRNA (2-fold), and 4) parathyroid hormone-stimulated adenosine 3',5'-cyclic monophosphate accumulation (2-fold). OP-1-induced changes in cell growth and gene expression were sensitive to cycloheximide and actinomycin D. Measurement of [3H]thymidine incorporation and alkaline phosphatase activity in situ revealed heterogeneity in the cellular responses to OP-1. Proliferating cells exhibited less alkaline phosphatase activity than nonproliferating cells, whereas cells expressing high levels of alkaline phosphatase incorporated little [3H]thymidine. Our data delineating the responses of mature differentiated osteoblasts to OP-1 suggest that potentiation of osteoblast differentiated function is an important component of bone morphogenesis in vivo.

This article has been cited by other articles:

				S.-Z. Lin, B. J. Hoffer, P. Kaplan, Y. Wang, and C. Y. Hsu Osteogenic Protein-1 Protects Against Cerebral Infarction Induced by MCA Ligation in Adult Rats • Editorial Comment Stroke, January 1, 1999; 30(1): 126 - 133. [Abstract] [Full Text] [PDF]